{
  "id": "964e55ef-c156-4888-96be-f617ee9ff67a",
  "protocol_number": null,
  "version": 1,
  "status": "under_review",
  "created_at": "2026-02-04T03:26:52.327654",
  "updated_at": "2026-02-04T04:28:11.473357",
  "submitted_at": "2026-02-04T03:27:11.253888",
  "approved_at": null,
  "expiration_date": null,
  "title": "Effects of amoxicillin on bacteria",
  "principal_investigator": {
    "name": "Ravi Tolwani",
    "role": "Principal Investigator",
    "email": "ravi@tolwani.com",
    "phone": null,
    "department": null,
    "qualifications": [],
    "responsibilities": []
  },
  "department": "Immunology",
  "funding_sources": [],
  "funding_agency_numbers": [],
  "study_duration": "12 months",
  "lay_summary": "Amoxicillin is an antibiotic that is commonly used to treat bacterial infections. This study aims to investigate the effectiveness of amoxicillin in treating infections caused by gram-negative bacteria, which are a type of bacteria that can be more difficult to treat.\n\nThe researchers will use 50 mice in this study, which will last for 12 months. The mice will be given amoxicillin to see how well it works in treating the bacterial infections. This is an important step in the research process, as the researchers have already tested amoxicillin in a laboratory setting and found that it is effective against these bacteria.\n\nBy conducting this study in mice, the researchers can better understand how amoxicillin works in a living organism and whether it can effectively treat infections caused by gram-negative bacteria. This information can then be used to develop better treatments for people who are suffering from these types of bacterial infections.",
  "personnel": [],
  "animals": [
    {
      "species": "Mouse",
      "scientific_name": null,
      "strain": "",
      "sex": "female",
      "age_range": null,
      "weight_range": null,
      "total_number": 50,
      "number_per_group": null,
      "number_of_groups": null,
      "source": "CRL",
      "vendor_name": null,
      "genetic_modification": "",
      "housing_requirements": null
    }
  ],
  "usda_category": "C",
  "total_animals": 50,
  "animal_number_justification": "To be completed.",
  "scientific_objectives": "Our goals are to determine the efficacy of amoxicillin on gram negative bacteria. ",
  "scientific_rationale": "Animals are needed next.  we have already tested in culture and amoxicillin works. ",
  "potential_benefits": "To be completed.",
  "replacement_statement": "",
  "reduction_statement": "50 mice are a mimum to see an effect ",
  "refinement_statement": "mice will be euthanized 48 hours after e coli innoculation. no clinical signs expected ",
  "literature_search": null,
  "experimental_design": "# Amoxicillin Administration Procedure for Mouse Infection Model\n\n## Overview\nThis procedure describes the administration of amoxicillin to laboratory mice for infection model studies. Amoxicillin is a beta-lactam antibiotic commonly used to treat bacterial infections in research settings.\n\n## Materials and Equipment\n\n### Reagents\n- Amoxicillin trihydrate powder (pharmaceutical grade)\n- Sterile saline (0.9% NaCl) or sterile water for injection\n- pH adjustment solution (if needed)\n\n### Equipment\n- Analytical balance (0.1 mg precision)\n- Sterile syringes (1 mL tuberculin syringes)\n- Sterile needles (25-27 gauge)\n- Sterile mixing containers\n- Vortex mixer\n- pH meter\n- 0.22 μm sterile filters\n- Animal restraint device or restraint technique materials\n- Personal protective equipment (gloves, lab coat, safety glasses)\n\n## Pre-Procedure Preparations\n\n### 1. Dosage Calculation\n- Standard dosing range: 20-100 mg/kg body weight\n- Common research dose: 50 mg/kg\n- Calculate total dose based on individual mouse weight\n- Example: 25g mouse × 50 mg/kg = 1.25 mg amoxicillin\n\n### 2. Solution Preparation\n1. Weigh appropriate amount of amoxicillin trihydrate\n2. Dissolve in sterile saline to achieve desired concentration (typically 5-10 mg/mL)\n3. Vortex until completely dissolved\n4. Check pH (should be 6.0-8.0); adjust if necessary\n5. Filter sterilize through 0.22 μm filter\n6. Prepare fresh solution daily (maximum 24-hour stability)\n\n### 3. Animal Preparation\n- Fast animals for 2-4 hours if oral administration planned\n- Weigh each mouse immediately before dosing\n- Record baseline health observations\n\n## Administration Routes\n\n### Route 1: Intraperitoneal (IP) Injection\n\n#### Procedure:\n1. Restrain mouse appropriately (scruff hold or restraint device)\n2. Position mouse head-down at 30-45° angle\n3. Identify injection site: lower right quadrant of abdomen\n4. Insert needle at 30-45° angle, 5-8 mm deep\n5. Aspirate gently to ensure no organ puncture\n6. Inject solution slowly and steadily\n7. Withdraw needle and apply gentle pressure\n8. Monitor injection site for leakage\n\n#### Volume Limits:\n- Maximum volume: 10 mL/kg (0.25 mL for 25g mouse)\n- Preferred volume: 5 mL/kg or less\n\n### Route 2: Oral Gavage\n\n#### Procedure:\n1. Restrain mouse in vertical position\n2. Use appropriate gavage needle (20-22 gauge, curved or straight)\n3. Measure insertion depth (tip of nose to last rib)\n4. Insert gavage needle along roof of mouth\n5. Advance slowly until reaching stomach\n6. Inject solution slowly (over 10-15 seconds)\n7. Withdraw needle carefully\n8. Monitor for aspiration signs\n\n#### Volume Limits:\n- Maximum volume: 10 mL/kg\n- Administer slowly to prevent aspiration\n\n### Route 3: Subcutaneous (SC) Injection\n\n#### Procedure:\n1. Restrain mouse and lift skin fold at scruff or flank\n2. Insert needle parallel to body wall into subcutaneous space\n3. Aspirate to ensure no blood vessel puncture\n4. Inject solution slowly\n5. Withdraw needle and massage injection site gently\n6. Monitor for swelling or irritation\n\n## Dosing Schedules\n\n### Prophylactic Treatment:\n- Begin 24 hours before infection challenge\n- Continue for duration of study\n- Typical frequency: Every 12 hours (BID) or every 8 hours (TID)\n\n### Therapeutic Treatment:\n- Begin at predetermined time post-infection\n- Duration: 5-10 days typical\n- Frequency: Every 8-12 hours depending on study design\n\n### Sample Dosing Regimen:\n- Day -1: Begin prophylactic dosing (if applicable)\n- Day 0: Infection challenge\n- Day 1-7: Therapeutic dosing every 12 hours\n- Monitor throughout treatment period\n\n## Monitoring and Observations\n\n### Immediate Post-Administration (0-2 hours):\n- Monitor for adverse reactions\n- Check injection site for swelling, redness, or leakage\n- Observe for signs of distress or pain\n- Document any abnormal behaviors\n\n### Daily Monitoring:\n- Body weight changes\n- Food and water consumption\n- General health assessment\n- Infection progression markers\n- Treatment efficacy indicators\n\n### Clinical Signs to Monitor:\n- Lethargy or hyperactivity\n- Changes in grooming behavior\n- Respiratory distress\n- Gastrointestinal upset\n- Injection site reactions\n\n## Safety Considerations\n\n### Personnel Safety:\n- Wear appropriate PPE\n- Handle amoxicillin powder in fume hood\n- Be aware of penicillin allergies among staff\n- Follow institutional biosafety guidelines\n\n### Animal Welfare:\n- Use appropriate anesthesia/analgesia if multiple procedures\n- Minimize stress during restraint and injection\n- Provide environmental enrichment\n- Follow institutional IACUC guidelines\n\n## Documentation Requirements\n\n### Record for Each Administration:\n- Date and time\n- Mouse identification\n- Body weight\n- Dose calculated and administered\n- Route of administration\n- Lot number of amoxicillin\n- Administrator initials\n- Any adverse observations\n\n### Study Documentation:\n- Preparation logs for solutions\n- Stability data\n- Dosing schedule adherence\n- Efficacy measurements\n- Adverse event reports\n\n## Quality Control\n\n### Solution Verification:\n- Verify concentration calculations\n- Check solution clarity and pH\n- Confirm sterility if required\n- Document preparation date/time\n\n### Administration Verification:\n- Double-check dose calculations\n- Verify correct mouse identification\n- Confirm proper injection technique\n- Document any deviations from protocol\n\n## Troubleshooting\n\n### Common Issues:\n- **Solution precipitation**: Adjust pH or temperature\n- **Injection site reactions**: Consider route change or dilution\n- **Poor efficacy**: Verify dosing accuracy and frequency\n- **Gastrointestinal upset**: Consider probiotics or route change\n\n### Emergency Procedures:\n- Severe allergic reactions: Immediate veterinary consultation\n- Injection complications: Monitor closely, provide supportive care\n- Overdose: Contact veterinarian, increase monitoring frequency\n\n## Storage and Disposal\n\n### Storage:\n- Store powder at room temperature, protected from light\n- Prepared solutions: refrigerate, use within 24 hours\n- Label all solutions with preparation date/time\n\n### Disposal:\n- Dispose of expired solutions according to institutional guidelines\n- Contaminated materials in biohazard waste\n- Needles and syringes in sharps containers\n\nThis procedure should be adapted based on specific study requirements, institutional guidelines, and regulatory requirements. Always consult with veterinary staff and follow approved animal use protocols.",
  "statistical_methods": "The sample size of 50 mice for a study can be considered a relatively small sample size, and its justification would depend on the specific research question, the expected effect size, and the statistical power required to detect meaningful differences.\n\nHere are a few points to consider regarding the sample size of 50 mice:\n\n1. Statistical power: The statistical power of a study is the likelihood of detecting an effect if it truly exists. A small sample size, such as 50 mice, may have limited statistical power, making it more difficult to detect small or moderate effects. This could increase the risk of a Type II error (failing to detect an effect when it is present).\n\n2. Effect size: The expected effect size is the magnitude of the difference or relationship that the researchers are interested in detecting. If the expected effect size is large, a smaller sample size may be justified. However, if the expected effect size is small or moderate, a larger sample size may be necessary to have sufficient statistical power.\n\n3. Variability in the population: The variability within the mouse population being studied can also affect the required sample size. If the population has high variability, a larger sample size may be needed to detect meaningful differences.\n\n4. Study design and analysis: The specific study design and the planned statistical analyses can also influence the justification for the sample size. For example, if the study involves repeated measures or complex statistical models, a larger sample size may be required.\n\nWithout more information about the specific research question, the expected effect size, the variability in the mouse population, and the planned statistical analyses, it is difficult to definitively assess whether a sample size of 50 mice is justified. In general, researchers should conduct a priori power analysis to determine the appropriate sample size based on the study's objectives and the expected effect size.\n\nIf the sample size of 50 mice is not sufficient to achieve the desired statistical power, the researchers may need to consider increasing the sample size or refining the study design to improve the likelihood of detecting meaningful effects.",
  "power_analysis": null,
  "group_assignments": [],
  "procedures": [
    {
      "name": "TBD",
      "description": "To be completed.",
      "frequency": null,
      "duration": null,
      "anesthesia_required": false,
      "anesthesia_protocol": null,
      "analgesia_required": false,
      "analgesia_protocol": null,
      "recovery_expected": true,
      "special_considerations": null
    }
  ],
  "procedure_timeline": null,
  "anesthesia_protocols": [],
  "analgesia_protocols": [],
  "monitoring_during_anesthesia": null,
  "surgical_procedures": [],
  "aseptic_technique": null,
  "post_operative_care": null,
  "multiple_survival_surgeries": false,
  "multiple_surgery_justification": null,
  "humane_endpoints": [
    {
      "criterion": "TBD",
      "measurement": "TBD",
      "threshold": "TBD",
      "action": "Euthanasia"
    }
  ],
  "monitoring_schedule": "# Veterinary Review: Mouse Infection Model with Amoxicillin Treatment\n\n## Study Overview\n**Species:** Laboratory mouse (*Mus musculus*)  \n**Intervention:** Amoxicillin administration for infection model  \n**Study Type:** Therapeutic efficacy/infection research\n\n## Pain Category Classification\n**USDA Category:** D (Pain/Distress with Appropriate Relief)\n- Infection induction causes moderate pain/distress\n- Amoxicillin treatment provides therapeutic relief\n- Additional analgesics may be warranted depending on infection severity\n\n## Monitoring Protocol\n\n### Clinical Observations (Daily minimum, BID during acute phase)\n- **Body weight:** Daily weighing, record ≥10% loss\n- **Body condition score:** 1-5 scale assessment\n- **Activity level:** Mobility, posture, social interaction\n- **Appearance:** Coat condition, eye discharge, dehydration signs\n- **Respiratory:** Rate, effort, sounds\n- **Temperature:** Core body temperature if indicated\n\n### Behavioral Indicators\n- Hunched posture\n- Reduced grooming\n- Decreased food/water consumption\n- Lethargy or hyperactivity\n- Vocalization changes\n- Isolation from cage mates\n\n### Infection-Specific Parameters\n- Wound assessment (if applicable)\n- Abscess formation/progression\n- Systemic signs of sepsis\n- Response to antibiotic therapy\n\n## Humane Endpoints\n\n### Mandatory Euthanasia Criteria\n- **Weight loss:** ≥20% from baseline\n- **Severe dehydration:** Skin tent >3 seconds, sunken eyes\n- **Moribund state:** Inability to remain upright, unresponsive\n- **Severe respiratory distress:** Open-mouth breathing, cyanosis\n- **Hypothermia:** Core temperature <35°C (95°F)\n- **Neurological signs:** Seizures, paralysis, head tilt\n\n### Early Intervention Points\n- **Weight loss:** 15-19% (increase monitoring, consider supportive care)\n- **Mild dehydration:** Subcutaneous fluids\n- **Reduced activity:** Environmental enrichment, palatable foods\n- **Pain indicators:** Analgesic administration per protocol\n\n## Amoxicillin Administration Guidelines\n\n### Dosing\n- **Standard dose:** 100-200 mg/kg BID PO\n- **Duration:** 5-10 days (infection-dependent)\n- **Route:** Oral gavage or drinking water\n\n### Monitoring for Adverse Effects\n- Gastrointestinal upset (diarrhea, reduced appetite)\n- Allergic reactions (rare in mice)\n- Secondary infections (opportunistic)\n\n## Supportive Care Recommendations\n- **Nutritional support:** High-calorie supplements, moistened food\n- **Hydration:** Subcutaneous fluids if indicated\n- **Environmental:** Warmed housing, soft bedding\n- **Analgesics:** Carprofen (5 mg/kg BID) or meloxicam (1-2 mg/kg SID) if needed\n\n## Documentation Requirements\n- Daily clinical observation records\n- Body weight logs with percentage changes\n- Medication administration logs\n- Adverse event reporting\n- Endpoint justification documentation\n\n## Emergency Contact Protocol\n**Veterinary contact required for:**\n- Any humane endpoint criteria met\n- Unexpected adverse reactions\n- Questions regarding animal welfare\n- Protocol deviations\n\n**Veterinarian:** [Contact information]  \n**After-hours emergency:** [Emergency contact]\n\n---\n**Veterinary Approval:** _________________ **Date:** _________  \n**Principal Investigator Acknowledgment:** _________________ **Date:** _________\n\n*This protocol should be reviewed by the Institutional Animal Care and Use Committee (IACUC) prior to study initiation.*",
  "responsible_person": null,
  "euthanasia_method": "CO2",
  "euthanasia_justification": null,
  "secondary_method": null,
  "avma_compliant": true,
  "hazardous_materials": [],
  "biohazard_level": null,
  "radiation_use": false,
  "ibc_approval": null,
  "additional_sections": {},
  "attachments": [],
  "notes": null
}